Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.


TSXV:MIR - Post by User

Post by august202013on May 18, 2023 12:17pm
131 Views
Post# 35454720

STILL STATUS QUO BUT STILL CORNERED

STILL STATUS QUO BUT STILL CORNERED VALUED of a CORNERED stock even though STATUS QUO  as reflected it's INDUSTRIAL AVERAGE and CURRENT (CASH-FLOW) VALUE.

As mentioned AGAIN based on previous QUARTERLY REPORTS CASH FLOW seems slightly negative to OPERATING expenses. Being in this INDUSTRY is still acceptable although WOULD have been a WHOLE different STORY in 2020 had BIG BROTHER been FAIR!

Next Quarterly FINANCIAL REPORT is KEY to MEDMIRA directors even though WON'T change MINORITY LONG-TERM SHAREHOLDER direction.

A huge deficit will be depressing as it will indicate not much SALES to support new OPERATING EXPENSES but a small deficit is VERY good and a SURPLUS or POSITIVE CASH flow will be HUGE! 
<< Previous
Bullboard Posts
Next >>